You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MBRX Exercise Disclosure
Foster Jonathan P. · SEC Form 4 · Filed Jun 24, 2026
Exercise
Reported value range
Not reported
Foster Jonathan P. Chief Financial Officer
MBRX
Transaction date
Jun 20, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 4 days later
MBRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 109 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-021610
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$217.2
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moleculin Biotech, Inc. MBRX | Exercise | Jun 22, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX | Disposition | Jun 22, 2026 | $127.92 |
| Moleculin Biotech, Inc. MBRX | Exercise | Jun 22, 2026 | $0 |
| Moleculin Biotech, Inc. MBRX Current | Exercise | Jun 20, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX | Disposition | Jun 20, 2026 | $89.28 |
| Moleculin Biotech, Inc. MBRX | Exercise | Jun 20, 2026 | $0 |